Eprosartan, Hydrochlorothiazide

FUTURAN PLUS 600 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

735,8 mg + 12,5 mg comprimido recubierto con películaSpainMarketedAuthorised 27 Jan 2005

In other countries

The same active substances on other registers, the same brand first.

Teveten PlusCanada · 600 MG + 12.5 MG · Tablet · BGP Pharma UlcSame form
Teveten Plus, filmomhulde tabletten 600/12,5 mgNetherlands · Filmomhulde tablet · Viatris Healthcare B.V.Same form
Teveten Plus 600-12.5MG Film Coated Tab.Saudi Arabia · Mylan Laboratories SASSame form
Teveten HCTUnited States · 600MG; 12.5MG, 600MG; 25MG · tablet · AbbvieSame form

Packs

Pack	Code	Status
FUTURAN PLUS 600 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos	650641

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Eprosartan, Hydrochlorothiazide

FUTURAN PLUS 600 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

735,8 mg + 12,5 mg comprimido recubierto con películaSpainMarketedAuthorised 27 Jan 2005

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
FUTURAN PLUS 600 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos	650641

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristicsAEMPS

Package leafletAEMPS

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Eprosartan, Hydrochlorothiazide
Strength: 735,8 mg + 12,5 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 27 Jan 2005
Registration: 66568
Marketing authorisation holder: Viatris Healthcare Limited
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica

Eprosartan + Hydrochlorothiazide · 735,8 mg + 12,5 mg · comprimido recubierto con película

Spain

TEVETENS PLUS 600 mg/12,5 mg, COMPRIMIDOS RECUBIERTOS CON PELICULAEprosartan + Hydrochlorothiazide · 735,8 mg + 12,5 mg · comprimido recubierto con películaSpain